Leit í EES-gagnagrunni
Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1083 of 31 May 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/1055 of 30 May 2023 setting out the rules on the sharing and prioritisation of satellite communication capacities, services, and user equipment to fulfil the function referred to in Article 66(2) of Regulation (EU) 2021/696 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/1054 of 30 May 2023 laying down rules for the application of Regulation (EU) 2021/696 of the European Parliament and of the Council as regards the service portfolio for the Governmental Satellite Communications services offered by the system established under the Union Space Programme
Commission Implementing Decision (EU) 2023/1053 of 30 May 2023 laying down rules for the application of Regulation (EU) 2023/588 of the European Parliament and of the Council as regards operational requirements for governmental services provided under Union Secure Connectivity Programme and its service portfolio
Commission Implementing Decision (EU) 2023/1017 of 23 May 2023 amending Implementing Decision (EU) 2020/1729 as regards the monitoring of methicillin-resistant Staphylococcus aureus (MRSA) in fattening pigs
Commission Implementing Decision (EU) 2023/1016 of 22 May 2023 amending Decision 2002/994/EC concerning certain protective measures with regard to the products of animal origin imported from China
Commission Implementing Decision (EU) 2023/985 of 15 May 2023 concerning certain interim emergency measures relating to African swine fever in Italy
Commission Implementing Decision (EU) 2023/984 of 15 May 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/975 of 15 May 2023 amending Commission Implementing Decision (EU) 2019/417 laying down guidelines for the management of the European Union Rapid Information System ‘RAPEX’ established under Article 12 of Directive 2001/95/EC of the European Parliament and of the Council on general product safety and its notification system
Commission Implementing Decision (EU) 2023/910 of 3 May 2023 amending Implementing Decision (EU) 2019/450 as regards the publication of references of European Assessment Documents for corrugated bitumen tiles or sheets and other construction products
Commission Implementing Decision (EU) 2023/872 of 20 April 2023 amending Implementing Decision (EU) 2022/2333 concerning certain emergency measures relating to sheep pox and goat pox in Spain
Commission Implementing Decision (EU) 2023/836 of 11 April 2023 amending Implementing Decision (EU) 2022/2333 concerning certain emergency measures relating to sheep pox and goat pox in Spain
Commission Implementing Decision (EU) 2023/816 of 5 April 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/733 of 3 April 2023 designating Union testing facilities for radio equipment and toys in accordance with Regulation (EU) 2019/1020 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/719 of 24 March 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
D088855/01
Commission Implementing Decision (EU) 2023/749 of 14 April 2023 amending Annexes I and II to Implementing Decision (EU) 2021/260 as regards the national measures which apply in Denmark concerning bacterial kidney disease (BKD) and infectious pancreatic necrosis (IPN) and the national measures which apply in the United Kingdom (Northern Ireland) concerning Ostreid herpesvirus-1μνar (OsHV-1μνar)
Commission Implementing Decision (EU) 2023/665 of 14 March 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/497 of 3 March 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/471 of 2 March 2023 postponing the expiry date of the approval of 4,5-Dichloro-2-octyl-2H-isothiazol-3-one for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/470 of 2 March 2023 not approving d-Allethrin as an existing active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/469 of 20 February 2023 amending the Annex to Implementing Decision (EU) 2021/641 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2023/468 of 25 November 2022 amending Decision 2007/116/EC as regards the introduction of an additional reserved number beginning with 116
Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council